Role of Prostate MR Imaging in Radiation Oncology

Cynthia Ménard; Eric Paulson; Tufve Nyholm; Patrick McLaughlin; Gary Liney; Piet Dirix; Uulke A van der Heide

doi:10.1016/j.rcl.2017.10.012

Role of Prostate MR Imaging in Radiation Oncology

Radiol Clin North Am. 2018 Mar;56(2):319-325. doi: 10.1016/j.rcl.2017.10.012. Epub 2017 Dec 14.

Authors

Cynthia Ménard¹, Eric Paulson², Tufve Nyholm³, Patrick McLaughlin⁴, Gary Liney⁵, Piet Dirix⁶, Uulke A van der Heide⁷

Affiliations

¹ Centre Hospitalier de l'Université de Montréal (CRCHUM), 900 St-Denis, Room 11.442, Montréal, QC H2X 0A9, Canada; TECHNA Institute, University of Toronto, 124-100 College Street, Toronto, ON M5G 1L5, Canada. Electronic address: Cynthia.Menard@UMontreal.ca.
² Radiation Oncology, Medical College of Wisconsin, 9200 Wisconsin Avenue, Milwaukee, WI 53226, USA; Radiology, Medical College of Wisconsin, 9200 Wisconsin Avenue, Milwaukee, WI 53226, USA; Biophysics, Medical College of Wisconsin, 9200 Wisconsin Avenue, Milwaukee, WI 53226, USA.
³ Department of Radiation Sciences, Umeå University, Umeå SE-90187, Sweden.
⁴ Department of Radiation Oncology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109, USA.
⁵ Medical Physics, Ingham Institute for Applied Medical Research and Liverpool Cancer Therapy Centre, 1, Campbell Street, Liverpool NSW 2170, Australia.
⁶ Department of Radiation Oncology, Iridium Cancer Network, Oosterveldlaan 24, 2610 Wilrijk (Antwerp), Belgium; Department of Molecular Imaging, Pathology, Radiotherapy and Oncology (MIPRO), University of Antwerp, Prinsstraat 13, 2000 Antwerp, Belgium.
⁷ Department of Radiation Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands.

PMID: 29420985
DOI: 10.1016/j.rcl.2017.10.012

Abstract

The use of prostate MR imaging in radiotherapy continues to evolve. This article describes its current application in the selection of treatment regimens, integration in treatment planning or simulation, and assessment of response. An expert consensus statement from the annual MR in RT symposium is presented, as a list of 21 key quality indicators for the practice of MR imaging simulation in prostate cancer. Although imaging requirements generally follow PIRADSv2 guidelines, additional requirements specific to radiotherapy planning are described. MR imaging-only workflows and MR imaging-guided treatment systems are expected to replace conventional computed tomography-based practice, further adding specific requirements for MR imaging in radiotherapy.

Keywords: Brachytherapy; Image-guidance; MR imaging; Prostate cancer; Radiotherapy.

Publication types

Review

MeSH terms

Brachytherapy / methods*
Humans
Magnetic Resonance Imaging / methods*
Male
Prostate / diagnostic imaging
Prostate / pathology
Prostatic Neoplasms / diagnostic imaging*
Prostatic Neoplasms / pathology
Prostatic Neoplasms / radiotherapy*
Radiation Oncology / methods*
Radiotherapy Planning, Computer-Assisted / methods*